Skip to main content
European Commission logo print header

Capitalising Notch Biomarkers in the Drug Development Market

Objetivo

"CapNotch is the translation from discovery of multimodal cancer biomarkers of the Notch pathway to a strong market proposition. Biomarker products for validating specificity, efficacy and toxicity of preclinical compounds that target this pathway are highly wanted by academia and industry and could fuel progress in this area. One step further lays the opportunity to exploit such biomarkers for patient stratification and treatment monitoring, as well for advancing clinical trials as for supporting clinical decision making. The outcome of CapNotch should guide the selection of the most feasible proposition."

Convocatoria de propuestas

ERC-2012-PoC
Consulte otros proyectos de esta convocatoria

Institución de acogida

UNIVERSITEIT MAASTRICHT
Aportación de la UE
€ 150 000,00
Dirección
MINDERBROEDERSBERG 4
6200 MD Maastricht
Países Bajos

Ver en el mapa

Región
Zuid-Nederland Limburg (NL) Zuid-Limburg
Tipo de actividad
Higher or Secondary Education Establishments
Contacto administrativo
Judith Doomen (Ms.)
Enlaces
Coste total
Sin datos

Beneficiarios (1)